We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

131 hedge funds and large institutions have $669M invested in Albany Molecular Research Inc in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 62 increasing their positions, 38 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

625% more call options, than puts

Call options by funds: $2.79M | Put options by funds: $385K

63% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 38

17% more capital invested

Capital invested by funds: $571M → $669M (+$97.8M)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding

Funds holding: 131 → 131 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
3.53%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
62
Reduced
38
Closed
11
Calls
$2.79M
Puts
$385K
Net Calls
+$2.41M
Net Calls Change
+$553K

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$35.1M
2
PCM
Palisade Capital Management
New Jersey
+$4.44M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$4.21M
4
BM
Bridger Management
New York
+$3.06M
5
RFC
Russell Frank Company
Washington
+$2.75M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$22.4M
2
IGM
Incline Global Management
New York
-$4.72M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$4.4M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.13M
5
PTC
Philadelphia Trust Company
Pennsylvania
-$2.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$6.1M +$910K +47,174 +19%
HA
27
Heartland Advisors
Wisconsin
$4.86M +$1.54M +79,872 +50%
PCM
28
Palisade Capital Management
New Jersey
$4.66M +$4.44M +230,235 New
MOACM
29
Mutual of America Capital Management
New York
$4.47M +$246K +12,750 +6%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$3.74M -$930K -48,200 -21%
Natixis Advisors
31
Natixis Advisors
Massachusetts
$3.54M -$11.1K -573 -0.3%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$3.06M +$294K +15,220 +11%
JP Morgan Chase
33
JP Morgan Chase
New York
$3.03M +$862K +44,683 +42%
GCP
34
GSA Capital Partners
United Kingdom
$2.99M +$664K +34,383 +30%
Principal Financial Group
35
Principal Financial Group
Iowa
$2.98M -$4.23K -219 -0.1%
FSA
36
Franklin Street Advisors
North Carolina
$2.91M +$544K +28,200 +24%
GC
37
Guggenheim Capital
Illinois
$2.84M +$454K +23,501 +20%
Deutsche Bank
38
Deutsche Bank
Germany
$2.74M -$1.13M -58,304 -30%
CS
39
Credit Suisse
Switzerland
$2.7M +$1.65M +85,518 +179%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$2.45M -$181K -9,400 -7%
CSC
41
Cove Street Capital
California
$2.43M – – –
Two Sigma Investments
42
Two Sigma Investments
New York
$2.32M +$2.22M +114,816 New
Ameriprise
43
Ameriprise
Minnesota
$2.29M +$64.2K +3,325 +3%
AA
44
Ancora Advisors
Ohio
$2.09M +$1.99M +103,300 New
BIM
45
BlackRock Investment Management
Delaware
$2M +$152K +7,855 +9%
Invesco
46
Invesco
Georgia
$1.92M +$483K +25,047 +36%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$1.88M +$383K +19,843 +27%
Bessemer Group
48
Bessemer Group
New Jersey
$1.84M – – –
TCIM
49
TIAA CREF Investment Management
New York
$1.75M -$243K -12,598 -13%
BF
50
BOK Financial
Oklahoma
$1.59M +$386 +20 +0%
1
2
3 4 5

AMRI Hedge Fund Activity: Q2 2015 in Review

131 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q2 2015, worth a combined $669M — up 17% from $571M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new AMRI positions and 11 closed out — a net gain of 1 holder — while 62 added to existing stakes and 38 trimmed.

The largest buyer was Visium Asset Management, adding an estimated $35.1M. The largest seller was HealthCor Management, exiting entirely with an estimated $22.4M sold.

  • 131 institutional investors held Albany Molecular Research Inc (AMRI) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $669M of Albany Molecular Research Inc stock for Q2 2015, up 17% quarter-over-quarter.
  • 12 funds opened new Albany Molecular Research Inc positions in Q2 2015 and 11 closed out, a net change of +1 holder.
  • The largest Albany Molecular Research Inc buyer in Q2 2015 was Visium Asset Management, an estimated $35.1M added.
  • The largest Albany Molecular Research Inc seller in Q2 2015 was HealthCor Management, an estimated $22.4M sold.

Based on aggregated 13F filings for Q2 2015.